Professor of Medicine, University Alabama
Infectious Disease
Dr. Michael S. Saag, MD
|
|
Give Review
Dr. Michael S. Saag practices Infectious Disease. He studied medicine at University of Louisville School of Medicine. University of Louisville School of Medicine is ranked 83 in research and 0 in primary care medicine He has 3 awards "America's Top Doctors", "Elected Member" and "Whos Who in Medicine and Healthcare". Michael S. Saag, MD has written publications. He has 104 publications published with PubMed. The lastest publication is: 'Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.' Michael S. Saag is registered with Medicare and accepts Medicare payments.
Publications
- Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV.
- Immunization Costs and Programmatic Barriers at an urban HIV Clinic.
- Quantitative Evaluation of an Instrument to Identify Chronic Pain in HIV-Infected Individuals.
- Factors Associated with Missed Psychiatry Visits in an Urban HIV Clinic.
- Viral suppression is associated with increased likelihood of colorectal cancer screening among persons living with HIV/AIDS.
- Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department.
- Engagement in Human Immunodeficiency Virus Care: Linkage, Retention, and Antiretroviral Therapy Adherence.
- Fixing a Hole in the HIV Safety Net.
- Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.
- Antiretroviral Treatment of Adult HIV Infection: 2014 Recommendations of the International Antiviral Society-USA Panel.
- Quantum Leaps, Microeconomics, and the Treatment of Patients With Hepatitis C and HIV Coinfection.
- Decline in locomotor functions over time in HIV-infected patients.
- Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label ...
- Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in six U.S. HIV clinics.
- Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.
- Qualitative Investigation of a Brief Chronic Pain Screening Tool in HIV-Infected Patients.
- HIV Viremia and Incidence of Non-Hodgkin Lymphoma in Patients Successfully Treated With Antiretroviral Therapy.
- Factors Associated with Delayed Hepatitis B Viral Suppression on Tenofovir Among HBV-HIV Coinfected Patients in the CNICS Cohort.
- The antiretroviral drug pipeline: prospects and implications for future treatment research.
- Pain is Independently Associated with Impaired Physical Function in HIV-Infected Patients.
- A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV.
- Low Back Pain and Associated Imaging Findings among HIV-Infected Patients Referred to an HIV/Palliative Care Clinic.
- Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.
- Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical...
- Impact of a computer-assisted, provider-delivered intervention on sexual risk behaviors in HIV-positive men who have sex with men (MSM) in a primary care setting.
- A Conceptual Framework for Understanding Chronic Pain in Patients with HIV.
- Physical Activity and Health Outcomes Among HIV-Infected Men Who Have Sex with Men: A Longitudinal Mediational Analysis.
- Erratum to: Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measures.
- Characteristics of an Ambulatory Palliative Care Clinic for HIV-Infected Patients.
- Durable Efficacy and Safety of Raltegravir versus Efavirenz When Combined With Tenofovir/Emtricitabine In Treatment-Naive HIV-1 Infected Patients: Final Five-Year Resu...
- Lack of Occult HIV Infection Among Non-AIDS-Defining Cancer Patients in Three Academic Oncology Clinics in the United States.
- Evaluation of the Single-Item Self-Rating Adherence Scale for Use in Routine Clinical Care of People Living with HIV.
- When to start: as soon as possible.
- Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients.
- New and investigational antiretroviral drugs for HIV infection: mechanisms of action and early research findings.
- Effect of persistency of first-line HIV antiretroviral therapy on clinical outcomes.
- Routine Depression Screening in an HIV Clinic Cohort Identifies Patients with Complex Psychiatric Co-morbidities Who Show Significant Response to Treatment.
- Multimorbidity Patterns in HIV-Infected Patients: The Role of Obesity in Chronic Disease Clustering.
- Viva No Difference!
- Maraviroc observational study: the impact of expanded resistance testing and clinical considerations for antiretroviral regimen selection in treatment-experienced pati...
- Pain, Mood, and Substance Abuse in HIV: Implications for Clinic Visit Utilization, ART Adherence, and Virologic Failure.
- Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study.
- HIV Now Firmly Established in the Middle Ages.
- Patient reported outcomes in routine care: advancing data capture for HIV cohort research.
- Early Retention in HIV Care and Viral Load Suppression: Implications for a Test and Treat Approach to HIV Prevention.
- Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.
- Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections.
- Underutilization of the AIDS drug assistance program: associated factors and policy implications.
- Age at cancer diagnosis among persons with AIDS.
- Temporal Trends in Presentation for Outpatient HIV Medical Care 2000-2010: Implications for Short-term Mortality.
- The Role of Toxicity-Related Regimen Changes in the Development of Antiretroviral Resistance.
- Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.
- Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system.
- Transmitted Drug Resistance in the CFAR Network of Integrated Clinical Systems Cohort: Prevalence and Effects on Pre-Therapy CD4 and Viral Load.
- Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life.
- Darunavir outcomes study: comparative effectiveness of virologic suppression, regimen durability, and discontinuation reasons for three-class experienced patients at 4...
- Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.
- Phase 2a study of the CCR5 monoclonal antibody PRO 140 administered intravenously to HIV-infected adults.
- Letter in response to the new SHEA guideline for healthcare workers with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus.
- Uncompensated medical provider costs associated with prior authorization for prescription medications in an HIV clinic.
- Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction.
- Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 version 1.0 viral load test.
- Late presentation for human immunodeficiency virus care in the United States and Canada.
- Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.
- Comparative efficacy versus effectiveness of initial antiretroviral therapy in clinical trials versus routine care.
- Antiretroviral prescribing patterns in treatment-naïve patients in the United States.
- Durability of initial antiretroviral therapy in a resource-constrained setting and the potential need for zidovudine weight-based dosing.
- Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden.
- A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.
- HIV/AIDS: the only thing constant...
- Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
- Gender differences in discontinuation of antiretroviral treatment regimens.
- Novel drug classes: entry inhibitors [enfuvirtide, chemokine (C-C motif) receptor 5 antagonists].
- Durability of Initial Antiretroviral Therapy in a Resource Constrained Setting and the Potential Need for Zidovudine Weight-Based Dosing.
- Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.
- Ryan White: an unintentional home builder.
- Effect of early versus deferred antiretroviral therapy for HIV on survival.
- Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.
- Missed visits and mortality among patients establishing initial outpatient HIV treatment.
- Racial disparities in HIV virologic failure: do missed visits matter?
- The therapeutic implications of timely linkage and early retention in HIV care.
- Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.
- Short-term discontinuation of HAART regimens more common in vulnerable patient populations.
- Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy.
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.
- Clinical inertia in the management of low-density lipoprotein abnormalities in an HIV clinic.
- Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy.
- Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
- Opt-out testing: who can afford to take care of patients with newly diagnosed HIV infection?
- Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIV clinic in the electronic medical record era.
- Failure to establish HIV care: characterizing the "no show" phenomenon.
- Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings.
- HIV care at a crossroads: the emerging crisis in the US HIV epidemic.
- Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings?
- Which policy to ADAP-T: waiting lists or waiting lines?
- A plea for justice for jailed medical workers.
- Ryan White CARE Act reauthorization: we need help.
- Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
- The experts speak. Burn-out among HIV care providers. Interview by Vicki Glaser.
- Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.
- Cigarette Smokers are Less Likely to Have Undetectable Viral Loads: Results From Four HIV Clinics.
- Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment: 48-week results from the MODERN study.
- HIV primary care providers-Screening, knowledge, attitudes and behaviors related to alcohol interventions.
Schools
University of Louisville School of Medicine
University Of Al Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Aetna
- Blue Card PPO
- Dental Blue 100/200/300
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
University of Alabama Medical Center -
University of Louisville School of Medicine
Hospital
-
University of Alabama Hospital -
Birmingham Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1700809548 | |
| NPPES Provider LastName | SAAG | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 6036.0 | |
| Distinct Opioid Count | 8.0 | |
| Opioid Claim Count | 278.0 | |
| Percent Opioid Claims | 4.61 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700809548 |
| Last Name Of The Provider | SAAG |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. James H. Willig, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Baddley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sonya L. Heath, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Senu K. Apewokin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Kaslow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward W. Hook III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael E. Coghlan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth M. Middlebrooks, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William I. Lapidus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shirin Banu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina A. Muzny, MD
This Doctor is OpenDoctor Recommended.
|